Triple Negative Breast Cancer (TNBC)

A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

Preoperative Chemotherapy, Pembrolizumab and Low or High Dose RADiation in an Expansion Cohort of Node(+), Triple Negative Breast Cancer

Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors

A Phase 1a/1b, First-Time-in-Human Study of CT-202, a Nectin-4 Directed Bispecific Antibody, in Participants With Recurring Triple Negative Breast, Colorectal, Urothelial Cancers

PREDICT-RD: ctDNA Surveillance in TNBC With Residual Disease

A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors

Study of XB010 in Subjects With Solid Tumors

Evaluating Ovarian Toxicity Outcomes Following Immunotherapy in Patients With Triple-Negative Breast Cancer (TNBC)

A Nurse-Led, Coping and Supportive Intervention for Patients With Triple-Negative Breast Cancer

Platform Study of ADC Rechallenge in ADC-treated Metastatic Breast Cancer

Biolosion Combined Standard Neoadjuvant Therapy to Treat Triple-negative Breast Cancer

Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced Cancers

Neoadjuvant Study of HIFU With or Without PD-1 Inhibitors Followed by Abraxane Plus Carboplatin in Triple-Negative Breast Cancer.

A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors

QL1706 Plus Chemotherapy as Neoadjuvant Therapy in Triple-Negative Breast Cancer

A Phase 1, Multicenter Imaging Study of LNTH-2403 in Participants With Locally Advanced or Metastatic Solid Tumors.

PQ203 in Advanced Malignant Tumors Including Triple Negative Breast Cancer

A Study to Assess CLBR001+ABBV-461 in Subjects With Locally Advanced or Metastatic Breast Cancer

A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors